AI

The Series C raise comes less than a year after the company secured $50 million in a Series B funding round.

Ian Shakil, chief strategy officer at Commure, explores the role of AI in clinical documentation and note-taking, emphasizing the importance of keeping humans in the loop and expanding the technology's impact across healthcare.

Patients are interested in AI to try and garner more information about their care or their child's care. Tools like ChatGPT are being utilized more by patients, says Dr. Samuel Browd of UW and Seattle Children's and the CMO at Proprio.

PanopticAI also claims to be the first in the city to obtain US FDA clearance for software as a medical device.

The company, in partnership with Microsoft, aims to develop cancer medicines, followed by treatments for autoimmune diseases and rare conditions.

AI models used to enhance cybersecurity include supervised, unsupervised machine learning and genAI that can take complex data and distill it down to something human-readable, says Etay Maor, Cato Networks' chief security strategist.

Ashkan Afkhami of BCG X sat down with MobiHealthNews during JPM to discuss the U.S. health system's strengths, challenges in cost control and the transformative potential of AI.

Project Stargate includes a partnership between Oracle's Larry Ellison, OpenAI's Sam Altman and SoftBank's Masayoshi Son that aims to enhance cancer detection and personalized vaccines.

Reimbursements, denials, AI, patient digital access, scheduling, patient experience, quality and safety are among the trends expected in 2025, says Michael Mainiero, chief digital and information officer for Catholic Health Long Island. 

AMD is making a $20 million equity investment to bolster Absci's drug discovery efforts and expand AMDs accelerators and ROCm software.